论文部分内容阅读
医疗改革,是一个牵动无数人的话题,医改20年,政府、医院、企业、研究机构,进行了无数次的设计与尝试。2014年,一家民营企业——滨杭集团也踏入了这个行列,他从医院建设者的身份,转型启动“投融资+建设+运营”的全领域、多元化战略模式,并以“医养结合、大专科、大数据”等创新基因开始了滨杭特色的医改尝试。滨杭集团掌门人邵毅判断,在中国经济增速放缓的新常态下,作为一项重要的民生事业,医疗产业始终是国家重点投入领域。现在,随着政策导向愈加明确,以及PPP模式带来的契机,社会资本进入医疗、养老的最好时机已经到来。他认为,未来,民营医院市场化前景广阔,但如何建立起获得老百姓信赖的品牌始终是赢得市场的关键因素,这也是滨杭集团制定未什么样的成果,又能够给正在进行来战略的核心指引。中的全国医疗改革带来什么样的启滨杭的医改试验到底能够取得示,我们将拭目以待。
The medical reform is a topic that affects countless people. After 20 years of medical reform, the government, hospitals, enterprises and research institutes have conducted numerous design and attempts. In 2014, Binhang Group, a private-owned enterprise, also stepped into the ranks. Starting from the identity of the hospital builder, he started the diversified strategic mode of “investment and financing, construction and operation,” and transformed “ ”Medical combination, college, big data" and other innovative genes began the reform of Binhang characteristics of medical reform attempt. Shao Yi, head of Binhang Group, judged that as an important cause of livelihood, the medical industry has always been a key national investment area under the new normal of a slowdown in China’s economic growth. Now, as the policy orientation becomes clearer and the chances brought by the PPP model have come, the best time has come for social capital to enter the medical service and provide for the aged. He believes that in the future, the market for private hospitals will have a bright future. However, how to establish a brand trusted by ordinary people has always been a key factor in winning the market. This is also the result of Binh Hang Group’s efforts to develop and bring the core to the ongoing strategy Guidelines. What kind of medical reform in the country brought about by medical reform in the country can be achieved, we will wait and see.